Abrilumab, CAS 1342290-43-0

Product Description: Abrilumab is a fully human monoclonal antibody directed against α4β7. Abrilumab selectively binds the α4β7 integrin heterodimer. Abrilumab can be used for the research of inflammatory bowel disease (IBD)[1].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Iris Dotan, et al. The role of integrins in the pathogenesis of inflammatory bowel disease: Approved and investigational anti-integrin therapies. Med Res Rev/[2]Christopher A Lamb, et al. Gut-Selective Integrin-Targeted Therapies for Inflammatory Bowel Disease. J Crohns Colitis. 2018 Aug 22;12(suppl_2):S653-S668.

CAS Number: 1342290-43-0

Molecular Weight: N/A

Compound Purity: 98.35

Research Area: Cancer; Infection; Inflammation/Immunology

Solubility: 10 mM in DMSO

Target: Integrin

• SKU: MEXHY-P99184-10
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99184-10
• Package Unit: 10 mg
• Quantity Unit: STK
• Conjugate: Unconjugated